Navigation Links
FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Date:10/14/2011

the level of a liver enzyme that may be indicative of tissue or liver damage at unsafe amounts.

The most serious side effect seen in about two percent of patients treated with Ferriprox was the development of agranulocytosis, a serious and potentially life-threatening reduction in the number of granulocytes (a type of white blood cell that fights infection).

The therapy is being approved under the FDA's accelerated approval program, designed to provide patients with earlier access to promising new drugs followed by further studies to confirm the drug's clinical benefit.

The accelerated approval program allows the agency to approve a drug to treat a serious disease based on clinical data showing that the drug has an effect on an endpoint that is reasonably likely to predict a clinical benefit to patients, or on an effect on a clinical endpoint other than survival or irreversible morbidity (illness).

ApoPharma has agreed to several post-marketing requirement and commitments. One commitment includes further study of the use of Ferriprox in patients with sickle cell disease who have transfusional iron overload.

Earlier this year, the U.S. Department of Health and Human Services (HHS) launched the Sickle Cell Disease (SCD) Initiative bringing together HHS agencies to enhance the quality and quantity of SCD data, develop best practice guidelines and quality of care metrics, improve health care delivery and coordination of care for patients with SCD, facilitate approval of new medical products, and expand research on SCD.  The post-marketing requirement for further study of Ferriprox aligns with the goals of the SCD Initiative.

Ferriprox is marketed by ApoPharma Inc. of Toronto.

For more information:

FDA: Office of Hematology and Oncology Products
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm091745.htm

FDA: Spotlight o
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... N.J. , March 2, 2015   ... new certification programs covering the most critical ... industry. Medical device manufacturers are experiencing ... rapid innovation, more complex products, and global supply ... In response, US FDA and global regulators are ...
(Date:3/2/2015)... -- Akron Children,s Hospital has been designated a Diagnostic Imaging ... Radiology (ACR), making it the first hospital in ... in the United States to ... the ACR as a DICOE provides validation that our ... national benchmarks," says Dr. Michael Rubin , chairman, ...
(Date:3/2/2015)... and MENLO PARK, Calif. , ... Inc. (OTCQX: DMPI) (DelMar and the Company), ... cancer therapies in new orphan drug indications, today ... from the U.S. Patent and Trademark Office (USPTO) ... and methods to improve the therapeutic benefit of ...
Breaking Medicine Technology:Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 2Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative ... tips to bring about self-renewal. A 30 day detox ... first cleaning house. According to Dr. Cutler, expert ... Between environmental toxins like heavy metals, people’s food now ... stress levels, we all have a level of toxic ...
(Date:3/2/2015)... March 02, 2015 GBCHealth, a ... catalyzing private sector activities and investments in global ... elected four new members to serve on the ... Paul Farmer, Chief Strategist and Co-founder of Partners ... University; Dr. Huma Abbasi, General Manager of Global ...
(Date:3/2/2015)... March 02, 2015 Just months ... warned against the use of power morcellators ( ... removal surgeries, insurer UnitedHealthCare is poised to restrict ... those devices. In a notification sent to physicians ... April, it would require pre-authorization for laparoscopic or ...
(Date:3/2/2015)... Doctors in Novara, Italy have found that talc ... for people with mesothelioma than other clinical factors. ... study on the Surviving Mesothelioma website. , Thoracic ... followed the cases of 172 mesothelioma patients ... , “Persistent lung expansion after pleural talc poudrage ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
Breaking Medicine News(10 mins):Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3
... Medical Center and The Sports Medicine Clinic are pleased ... MD has joined the medical staff. He brings nearly ... shoulder and elbow surgery.Dr. Smith received his medical degree ... Medicine in Springfield, IL. He completed an internship ...
... current and future mobility initiatives with enterprise WLAN solution ... Calif., Jan. 20 Motorola, Inc. (NYSE: ... General Hospital has deployed its wireless LAN (WLAN) solution ... initiatives. Montreal Jewish General Hospital is a 680-bed facility ...
... January 20 Elsevier,the world,s leading publisher ... services, announced today the acquisition of the,publishing ... Over the last,18 months, Elsevier and William ... print distribution of William Andrew books globally,outside ...
... today that Lew Bennett has been named President and will ... with him over 48 years experience in the medical device ... Mr. Bennett,s love of a new challenge and dedication to ... and CEO, Mahmoud Abdelgany commented, "We are really excited to ...
... Corporation,(Nasdaq: VOLC ), a leader in the ... treatment of coronary and peripheral artery,disease, today commented on ... as well as their FFR pressure guide wires following ... Joe Burnett, Vice President of Marketing ...
... Facilities will face difficulty obtaining credit for capital expenditures, ... According to Millennium Research Group,s (MRG,s) US Markets ... medical facilities will face increased difficulty obtaining credit at ... to the ongoing US economic crisis. With the ...
Cached Medicine News:Health News:Orthopaedic Surgeon Kevin Smith, MD, Joins Northwest Hospital & Medical Center and The Sports Medicine Clinic 2Health News:Montreal Jewish General Hospital Improves Care and Reduces Costs With Motorola's Enterprise Mobility Solution 2Health News:Montreal Jewish General Hospital Improves Care and Reduces Costs With Motorola's Enterprise Mobility Solution 3Health News:Elsevier Acquires William Andrew Publishing 2Health News:Elsevier Acquires William Andrew Publishing 3Health News:Custom Spine Announces Lew Bennett as President 2Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 2Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 3Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 4Health News:Spending on Integrated Operating Rooms to Slow in 2009, But Expected to Recover in 2010 2
The electrically active helix of CapSureFix Novus lead is designed to extend easily for active fixation and retract for venous passage....
... presents the Streamline family of temporary sensing ... the gold standard in temporary pacing leads ... them easy to use and less traumatic ... Unipolar Pediatric Temporary Pacing Lead is designed ...
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Medicine Products: